CorNova

About CorNova

CorNova, Inc. was a medical device company established in 2003 with a focus on developing endovascular products. The company's primary mission was to address common complications associated with stent procedures, namely in-stent restenosis and thrombosis, which involve scar tissue growth and clot formation within the stent, respectively.

The firm was founded by Eric Ryan and was headquartered in Burlington, Massachusetts. Over its operational history, CorNova managed to secure $10.9 million in funding across four rounds, with its initial funding round occurring in April 2005. The primary institutional investor noted was Implant Sciences. The company also established a presence in Germany and Argentina.

CorNova's main product was the FiberHalo, a stent deployment and angioplasty catheter. This device integrated fiber optics into the catheter to allow for precise measurement of the blood vessel from within the balloon. This functionality aimed to ensure optimal stent expansion, a critical factor in preventing stent failure. In addition to the FiberHalo, the company also developed the Valecor Platinum, a CE-marked stent. The company's business model centered on the development and sale of these specialized medical devices to healthcare practitioners performing endovascular procedures. According to reports, CorNova is now a deadpooled company.